# Acetazolamide on REM OSA

> **NCT05589792** · PHASE1,PHASE2 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 11 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Placebo oral capsule
- **DRUG:** Acetazolamide

## Key facts

- **NCT ID:** NCT05589792
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-30
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05589792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05589792, "Acetazolamide on REM OSA". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05589792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*